Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI contributes to WHO proposed framework for evaluating the effectiveness of new COVID-19 vaccines

August 17, 2022

Global health experts urge developers to plan for vaccine equity in new commentary.

Read more

Features

Read: WHO preferred product characteristics for monoclonal antibodies (mAbs) for HIV prevention

July 27, 2022

Guide aims to ensure future HIV mAb products are affordable and globally accessible.

Read more

Features

IAVI at AIDS 2022

July 15, 2022

IAVI to participate in the 24th International AIDS Conference beginning July 29 in Montreal, Canada, and virtually.

Read more

Features

IAVI Pride 2022

July 13, 2022

IAVI colleagues share their reflections on the importance of Pride for the global HIV response and global health research.

Read more

Features

HVAD 2022: An HIV vaccine developed with the people it seeks to benefit most

May 17, 2022

On this HVAD, our colleagues share perspectives on how an HIV vaccine can be developed with the people it seeks to benefit most.

Read more

Features

Meet the IAVI scientist who developed a new HIV test for resource-limited settings

May 11, 2022

Dr. Catherine Namugga Kibirige, research associate, research team, IAVI Human Immunology Laboratory – Imperial College London

Read more

Features

IAVI salutes the confirmation of John Nkengasong as head of PEPFAR

May 6, 2022

Nkengasong was a founding leader of PEPFAR and served on IAVI’s board of directors.

Read more

Features

HVTN 302 begins first dosing of mRNA HIV vaccine antigens

March 17, 2022

HVTN, NIAID, and Moderna partner on trial of HIV Env trimers designed by IAVI's William Schief.

Read more